SEC Company Response from Lifevantage (LFVN) — Mar 18, 2026
Lifevantage Corp
Date: March 18, 2026 · CIK: 0000849146 · Accession: 0001193125-26-113550
AI Filing Summary & Sentiment
File numbers found in text: 333-294183
Show Raw Text
CORRESP 1 filename1.htm CORRESP March 18, 2026 VIA EDGAR Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes Re: Acceleration Request of LifeVantage Corporation Registration Statement on Form S-3 Filed March 10, 2026 (File No. 333-294183) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, LifeVantage Corporation (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Friday, March 20, 2026, or as soon thereafter as practicable. The Registrant hereby authorizes Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration. Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060. Very truly yours, /s/ Carl A. Aure Carl A. Aure Chief Financial Officer